Wellgistics Health Inc. Financials
This page shows Wellgistics Health Inc. (WGRX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Wellgistics Health Inc. passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, Wellgistics Health Inc. generates $0.18 in operating cash flow (-$1.2M OCF vs -$6.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Wellgistics Health Inc. earns $-7.4 in operating income for every $1 of interest expense (-$6.1M vs $831K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Wellgistics Health Inc. generated $18.1M in revenue in fiscal year 2024.
Wellgistics Health Inc.'s EBITDA was -$5.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
Wellgistics Health Inc. reported -$6.9M in net income in fiscal year 2024. This represents a decrease of 136.8% from the prior year.
Wellgistics Health Inc. earned $-0.15 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 150.0% from the prior year.
Wellgistics Health Inc. held $1.0M in cash against $11.5M in long-term debt as of fiscal year 2024.
Wellgistics Health Inc. had 51M shares outstanding in fiscal year 2024. This represents an increase of 14.2% from the prior year.
Wellgistics Health Inc.'s gross margin was 9.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs.
Wellgistics Health Inc.'s operating margin was -33.9% in fiscal year 2024, reflecting core business profitability.
Wellgistics Health Inc.'s net profit margin was -37.8% in fiscal year 2024, showing the share of revenue converted to profit.
WGRX Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M-61.3% | $7.8M-28.3% | $10.9M | N/A | $5.7M+12638.8% | $45K | N/A | N/A |
| Cost of Revenue | $2.8M-61.8% | $7.3M-28.4% | $10.2M | N/A | $5.2M+10828.6% | $47K | N/A | N/A |
| Gross Profit | $231K-54.3% | $506K-27.0% | $693K | N/A | $521K+20086.3% | -$3K | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $30.2M+520.8% | $4.9M-84.4% | $31.2M | N/A | $1.8M+215.3% | $570K+615.1% | $80K | N/A |
| Operating Income | -$31.5M-473.6% | -$5.5M+82.5% | -$31.3M | N/A | -$1.7M-204.5% | -$573K-618.4% | -$80K | N/A |
| Interest Expense | $1.4M+20.4% | $1.2M+8.2% | $1.1M | N/A | $138K+10412.9% | $1K-61.0% | $3K | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$34.3M-414.3% | -$6.7M+79.4% | -$32.4M | N/A | -$1.9M-225.1% | -$574K-590.9% | -$83K | N/A |
| EPS (Diluted) | $-0.46-318.2% | $-0.11+82.3% | $-0.62 | N/A | $-0.04-300.0% | $-0.01 | $0.00 | N/A |
WGRX Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.8M-2.7% | $54.2M-6.6% | $58.1M+1.3% | $57.3M | N/A | N/A | N/A | $338K |
| Current Assets | $12.8M-5.1% | $13.5M-18.4% | $16.6M+9.1% | $15.2M | N/A | N/A | N/A | $338K |
| Cash & Equivalents | $4.2M+907.0% | $420K-83.3% | $2.5M+144.7% | $1.0M | N/A | N/A | N/A | $1K |
| Inventory | $7.5M-17.0% | $9.0M-7.2% | $9.7M+2.3% | $9.5M | N/A | N/A | N/A | N/A |
| Accounts Receivable | $1.1M-49.1% | $2.2M-23.6% | $2.8M+3.8% | $2.7M | N/A | N/A | N/A | N/A |
| Goodwill | $16.2M0.0% | $16.2M0.0% | $16.2M0.0% | $16.2M | N/A | N/A | N/A | N/A |
| Total Liabilities | $46.0M-13.7% | $53.3M-0.5% | $53.6M+5.9% | $50.6M | N/A | N/A | N/A | $3.2M |
| Current Liabilities | $32.7M-22.8% | $42.4M-8.3% | $46.2M+21.5% | $38.0M | N/A | N/A | N/A | $2.9M |
| Long-Term Debt | $12.6M+24.8% | $10.1M-58.1% | $24.1M+110.6% | $11.5M | N/A | N/A | N/A | N/A |
| Total Equity | $6.8M+648.7% | $905K-79.8% | $4.5M-33.5% | $6.7M-32.6% | $10.0M+417.2% | -$3.1M-5.5% | -$3.0M-2.9% | -$2.9M |
| Retained Earnings | -$83.2M-70.2% | -$48.9M-15.8% | -$42.2M-332.4% | -$9.8M | N/A | N/A | N/A | -$2.9M |
WGRX Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.1M+45.4% | -$2.1M-54.3% | -$1.3M+48.6% | -$2.6M-352.9% | $1.0M+214.5% | $330K+956.3% | $31K | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$221K-67.6% | -$132K+51.7% | -$273K-134.0% | $803K+354.0% | -$316K | N/A | N/A | N/A |
| Financing Cash Flow | $5.2M+4419.7% | $114K-96.3% | $3.1M+51.2% | $2.1M+45405.9% | $5K+100.8% | -$538K-306.9% | $260K | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
WGRX Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q3'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.7%+1.2pp | 6.5%+0.1pp | 6.4% | N/A | 9.2%+15.0pp | -5.9% | N/A | N/A |
| Operating Margin | -1047.1%-976.5pp | -70.6%+218.0pp | -288.6% | N/A | -30.8%+1255.8pp | -1286.5% | N/A | N/A |
| Net Margin | -1139.0%-1053.4pp | -85.6%+212.9pp | -298.5% | N/A | -32.9%+1256.5pp | -1289.5% | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -65.0%-52.7pp | -12.3%+43.5pp | -55.9% | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.39+0.1 | 0.32-0.0 | 0.36-0.0 | 0.40 | N/A | N/A | N/A | 0.12 |
| Debt-to-Equity | 1.86-9.3 | 11.16+5.8 | 5.39+3.7 | 1.70 | N/A | N/A | N/A | -1.12 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.40), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Wellgistics Health Inc.'s annual revenue?
Wellgistics Health Inc. (WGRX) reported $18.1M in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Wellgistics Health Inc. profitable?
No, Wellgistics Health Inc. (WGRX) reported a net income of -$6.9M in fiscal year 2024, with a net profit margin of -37.8%.
What is Wellgistics Health Inc.'s earnings per share (EPS)?
Wellgistics Health Inc. (WGRX) reported diluted earnings per share of $-0.15 for fiscal year 2024. This represents a -150.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Wellgistics Health Inc.'s EBITDA?
Wellgistics Health Inc. (WGRX) had EBITDA of -$5.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Wellgistics Health Inc. have?
As of fiscal year 2024, Wellgistics Health Inc. (WGRX) had $1.0M in cash and equivalents against $11.5M in long-term debt.
What is Wellgistics Health Inc.'s gross margin?
Wellgistics Health Inc. (WGRX) had a gross margin of 9.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Wellgistics Health Inc.'s operating margin?
Wellgistics Health Inc. (WGRX) had an operating margin of -33.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Wellgistics Health Inc.'s net profit margin?
Wellgistics Health Inc. (WGRX) had a net profit margin of -37.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Wellgistics Health Inc.'s operating cash flow?
Wellgistics Health Inc. (WGRX) generated -$1.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Wellgistics Health Inc.'s total assets?
Wellgistics Health Inc. (WGRX) had $57.3M in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Wellgistics Health Inc. have outstanding?
Wellgistics Health Inc. (WGRX) had 51M shares outstanding as of fiscal year 2024.
What is Wellgistics Health Inc.'s current ratio?
Wellgistics Health Inc. (WGRX) had a current ratio of 0.40 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Wellgistics Health Inc.'s debt-to-equity ratio?
Wellgistics Health Inc. (WGRX) had a debt-to-equity ratio of 1.70 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Wellgistics Health Inc.'s return on assets (ROA)?
Wellgistics Health Inc. (WGRX) had a return on assets of -12.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Wellgistics Health Inc.'s cash runway?
Based on fiscal year 2024 data, Wellgistics Health Inc. (WGRX) had $1.0M in cash against an annual operating cash burn of $1.2M. This gives an estimated cash runway of approximately 10 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Wellgistics Health Inc.'s Piotroski F-Score?
Wellgistics Health Inc. (WGRX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Wellgistics Health Inc.'s earnings high quality?
Wellgistics Health Inc. (WGRX) has an earnings quality ratio of 0.18x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Wellgistics Health Inc. cover its interest payments?
Wellgistics Health Inc. (WGRX) has an interest coverage ratio of -7.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.